Oligomannate

China flag
Asia

Biogen, Pfizer, Lilly and more win China NRDL coverage

Biogen said its spinal muscular atrophy therapy Spinraza now boasts the distinction of being the first high-value rare disease drug included in NRDL.
Angus Liu Dec 3, 2021 10:15am
A nurse holding the hands of an elderly patient

Did this obscure Chinese firm just break the Alzheimer's curse?

Nov 4, 2019 11:13am